North America Deep Brain Simulation Market Forecast to 2030
North America Deep Brain Simulation Market Forecast to 2030 – Regional Analysis – by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson’s Disease, Tremor, Dystonia, Epilepsy, Alzheimer’s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Prevalence of Neurological Disorders Drive North America Deep Brain Simulation Market
The geriatric population is susceptible to neurological diseases. Neuropathy, Parkinson’s disease, Alzheimer’s disease, and dystonia are among the most common neurological disorders affecting older people. According to the National Institutes of Health (NIH), 8.5% of the world’s population (i.e., around 617 million people) are 65 and above. Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson’s Foundation, Parkinson’s symptoms are common at an average age of 60. The Canadian Psychological Association states that about 2% of the population suffers from obsessive-compulsive disorder (OCD). According to the World Health Organization (WHO), neurological diseases contribute 6.3% to the global disease burden and are one of the leading causes of death across the world. In addition, 13.2% of deaths in developed countries and 16.8% in low- and middle-income countries are reported due to neurological diseases. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions such as deep brain stimulators (DBS). Therefore, growing awareness regarding the burden of neurological disorders, the growing geriatric population, and the increasing prevalence of neurological diseases propel the demand for deep brain stimulators as a therapy.
North America Deep Brain Simulation Market Overview
The rising prevalence of neurological diseases such as Parkinson’s disease (PD), increasing awareness about neurological disorders, positive research results, and growing investments in developing transcranial stimulators are among the main factors driving the overall deep brain stimulation market growth in the US. Deep brain stimulation (DBS) devices have been observed to be effective in controlling the tremors associated with Parkinson’s disease. Low dopamine levels and other genetic factors are among the main causes of Parkinson’s disease. According to a study titled “2022 Alzheimer’s disease facts and figures” published in the Alzheimer’s Association, nearly 6.5 million Americans aged 65 and above were found to have Alzheimer’s disease in 2022, and that number is projected to rise to 13.8 million by 2060. Technological advancements and new product launches drive the growth of the US deep brain stimulation market. In January 2020, Abbott’s Infinity DBS System received US Food and Drug Administration (FDA) approval for treating Parkinson’s disease. This system allows for the targeted treatment of a specific area of the brain, called the inner globus pallidus (GPi), which is associated with the symptoms of Parkinson’s disease. The US FDA approved the Verses deep brain stimulation device system for treating Parkinson’s disease in December 2017 for use by Boston Scientific Corporation. According to the Parkinson’s Foundation, around 1 million people in the US are suffering from Parkinson’s disease, which is expected to increase to 1.2 million by 2030. Therefore, the increasing prevalence of neurological diseases and technological advancements fuel the North America deep brain simulation market growth in the US.
North America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)
North America Deep Brain Simulation Market Segmentation
The North America deep brain simulation market is segmented into product, application, end user, and country.
Based on product, the North America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the North America deep brain simulation market.
Based on application, the North America deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. In 2022, the Parkinson’s disease segment registered the largest share in the North America deep brain simulation market.
Based on end user, the North America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the North America deep brain simulation market.
Based on country, the North America deep brain simulation market is segmented into the US, Canada, Mexico. In 2022, the US registered the largest share in the North America deep brain simulation market.
Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Newronika SpA are some of the leading companies operating in the North America deep brain simulation market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team Market research, the North America deep brain simulation market was valued at US$ 282.86 million in 2022 and is expected to reach US$ 549.78 million by 2030, registering a CAGR of 8.7% from 2022 to 2030. Technological advancements and approvals in deep brain stimulation and rising prevalence of neurological disorders are the critical factors attributed to the North America deep brain simulation market expansion.
Robotic implantation, multi-target stimulation, improved microelectrode designs, rechargeable pulse generators, and personalized, targeted programming are among the technological advancements in deep brain stimulation (DBS). Owing to these advancements, DBS devices show fewer side effects and improved efficacy and symptom relief in Parkinson’s patients compared to traditional methods. Abbott’s Infinity Deep Brain Stimulation System is a technologically advanced new DBS that helps the patients manage their symptoms. It is the first wireless iOS software DBS mobile platform that has offered efficient and personalized therapy management with reduced risk of side effects.
In addition, there is an increase in FDA approvals for deep brain stimulation (DBS) devices in clinical applications such as tremors, severe obsessive-compulsive disorder, and dystonia. For instance, in March 2020, NeuroPace, Inc. received approval from the US FDA for MRI labeling its RNA system. Therefore, technological advancements in DBS are expected to create opportunities for the global deep brain stimulation market during the forecast period.
On the contrary, side effects associated with deep brain stimulation hurdles the growth of North America deep brain simulation market.
Based on product, the North America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. The dual channel deep brain stimulator segment held 50.7% share of North America deep brain simulation market in 2023, amassing US$ 143.46 million. It is projected to garner US$ 300.78 million by 2030 to expand at 9.7% CAGR during 2022–2030.
Based on application, the North America deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. The Parkinson’s disease segment held 62.6% share of North America deep brain simulation market in 2023, amassing US$ 182.12 million. It is projected to garner US$ 359.74 million by 2030 to expand at 8.9% CAGR during 2022–2030.
Based on end user, the North America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. The hospitals segment held 55.3% share of North America deep brain simulation market in 2022, amassing US$ 156.37 million. It is projected to garner US$ 318.58 million by 2030 to expand at 9.3% CAGR during 2022–2030.
Based on country, the North America deep brain simulation market is segmented into the US, Canada, Mexico. Our regional analysis states that the US captured 88.8% share of North America deep brain simulation market in 2022. It was assessed at US$ 251.12 million in 2022 and is likely to hit US$ 489.22 million by 2030, exhibiting a CAGR of 8.7% during 2022–2030.
Key players operating in the North America deep brain simulation market report Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Newronika SpA, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America deep brain simulation market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the North America deep brain simulation market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the deep brain simulation market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 North America Deep Brain Stimulation Market, by Region (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Deep Brain Simulation Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Comparison Analysis
4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
4.3.2 Lesioning Procedures in Neurological Disorders
4.3.3 Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country
5. North America Deep Brain Simulation Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Prevalence of Neurological Disorders
5.1.2 Increasing Demand for Minimally Invasive Surgery
5.2 Market Restraints
5.2.1 Side Effects Associated with Deep Brain Stimulation
5.3 Market Opportunities
5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact Analysis
6. Deep Brain Simulation Market – North America Market Analysis
6.1 North America Deep Brain Simulation Market Revenue (US$ Mn), 2022 – 2030
7. North America Deep Brain Simulation Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 North America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Single Channel Deep Brain Stimulator
7.3.1 Overview
7.3.2 Single Channel Deep Brain Stimulator: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Dual Channel Deep Brain Stimulator
7.4.1 Overview
7.4.2 Dual Channel Deep Brain Stimulator: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Software and Accessories
7.5.1 Overview
7.5.2 Software and Accessories: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Deep Brain Simulation Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 North America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Parkinson’s Disease
8.3.1 Overview
8.3.2 Parkinson’s Disease: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Tremor
8.4.1 Overview
8.4.2 Tremor: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer’s Disease
8.5.1 Overview
8.5.2 Alzheimer’s Disease: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Dystonia
8.6.1 Overview
8.6.2 Dystonia: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Epilepsy
8.7.1 Overview
8.7.2 Epilepsy: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Deep Brain Simulation Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 North America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Neurology Clinics
9.4.1 Overview
9.4.2 Neurology Clinics: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Deep Brain Simulation Market – Country Analysis
10.1 Overview
10.1.1.1 North America Deep Brain Simulation Market, by Country
10.1.1.2 US
10.1.1.2.1 Overview
10.1.1.2.2 US Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 US Deep Brain Simulation Market, by Product
10.1.1.2.4 US Deep Brain Simulation Market, by Application
10.1.1.2.5 US Deep Brain Simulation Market, by End User
10.1.1.3 Canada
10.1.1.3.1 Overview
10.1.1.3.2 Canada Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Canada Deep Brain Simulation Market, by Product
10.1.1.3.4 Canada Deep Brain Simulation Market, by Application
10.1.1.3.5 Canada Deep Brain Simulation Market, by End User
10.1.1.4 Mexico
10.1.1.4.1 Overview
10.1.1.4.2 Mexico Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Mexico Deep Brain Simulation Market, by Product
10.1.1.4.4 Mexico Deep Brain Simulation Market, by Application
10.1.1.4.5 Mexico Deep Brain Simulation Market, by End User
11. Pre & Post Covid-19 Impact
11.1 Pre & Post Covid-19 Impact
12. Deep Brain Simulation Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in Deep Brain Stimulation Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. North America Deep Brain Simulation Market, Key Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Boston Scientific Corp
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Newronika SpA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Deep Brain Simulation Market Segmentation
Table 2. Comparison of Deep Brain Stimulation and Lesioning Procedures
Table 3. Deep Brain Stimulation Surgical Procedures Performed in 2022, by Country.
Table 4. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 5. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 6. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 7. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 8. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 9. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 10. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 11. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 12. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 13. Recent Organic Growth Strategies in Deep Brain Stimulation Market
Table 14. Recent Inorganic Growth Strategies in the North America deep brain simulation market
Table 15. Glossary of Terms, North America Deep Brain Simulation Market
LIST OF FIGURES
Figure 1. North America Deep Brain Simulation Market Segmentation, By Country
Figure 2. North America – PEST Analysis
Figure 3. North America Deep Brain Simulation Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Deep Brain Simulation Market Revenue (US$ Mn), 2022 – 2030
Figure 6. North America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Single Channel Deep Brain Stimulator: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Dual Channel Deep Brain Stimulator: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software and Accessories: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. North America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Parkinson’s Disease: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Tremor: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Alzheimer’s Disease: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dystonia: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Neurology Clinics: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Ambulatory Surgical Centers: North America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. North America Deep Brain Simulation Market, 2022 ($Mn)
Figure 23. North America Deep Brain Simulation Market, By Key Countries, 2022 And 2030 (%)
Figure 24. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 26. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 27. Pre & Post Covid-19 Impact
Figure 28. Growth Strategies in Deep Brain Stimulation Market
The List of Companies – North America Deep Brain Simulation Market
o Abbott Laboratories
o Boston Scientific Corp
o Medtronic Plc
o Newronika SpA
You must be logged in to post a review.
Reviews
There are no reviews yet.